Skip to main content

Table 1 Characteristics of the included studies

From: The Association of obesity with vascular complications after liver transplantation

Reference

Region

Sample Size

Periods

Recipient Age

MELD Score

Male (%)

Most common etiology

BMI ≥ 30

BMI < 30

BMI ≥ 30

BMI < 30

Nair (2001)a [15]

America

21Φ

64b

1994-1996

46.7 ± 10.5Φ

46.0 ± 12.6b

/

82.4

HCV

Fujikawa (2006) [21]

America

167

533

1990–2005

51.0 ±?

49.5 ±?

18.5 ±?

61.3

/

Lamattina (2012) [13]

America

306

482

1997–2008

53.4 ± 8.8

52.6 ± 9.9

19.8 ± 8.8

63.1

Alcohol

Hakeem (2013) [16]

The UK

218

1107

1994–2009

50.9 ± 8.5

47.4 ± 13.0

19.7 ± 10.7

56.9

cholestasis

Tanaka (2013) [22]

Canada

149

358

2000–2006

52.9 ± 8.6

51.4 ± 10.5

16.2 ± 8.0

69.0

HCV

Gunay (2013) [23]

Europe

74

296

2004–2012

52.4 ± 8.4

50.4 ± 11.3

16.7 ± 6.6

76.8

HBV

Triguero (2015)a [24]

Europe

11(BMI > 35)

36(BMI 20–25)

2007–2013

53 ±?(45–64)

54.5 ±?

15 ±?

78.7

Alcohol

Molina (2016) [14]

Europe

73

135

2008–2014

54.8 ± 7.7

52.8 ± 10.3

18.2 ± 5.0

84.1

Alcohol

  1. aThese studies were not included because of inconsistent grouping with others. Φ: BMI > 31.1 for men and 32.3 for women
  2. bBMI < 27.8 for men and < 27.3 for women; MELD: model for end-stage liver disease; HBV: hepatic B virus; HCV: hepatic C virus